ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

25 hedge funds and large institutions have $4.75M invested in Enlivex Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
3
Closed
4
Calls
$56K
Puts
$311K
Net Calls
-$255K
Net Calls Change
-$462K

Top Buyers

1
AIM
1
ARK Investment Management
Florida
$2.43M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$205K
3
Jane Street
3
Jane Street
New York
$294K
4
SIGI
4
Susquehanna International Group (Ireland)
Ireland
$126K
5
Group One Trading
5
Group One Trading
Illinois
$126K

Top Sellers

1
GG
1
Golden Green
South Carolina
$0
2
Simplex Trading
2
Simplex Trading
Illinois
$0
3
Marshall Wace
3
Marshall Wace
United Kingdom
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$356K
5
UBS Group
5
UBS Group
Switzerland
$99K
Name Holding Trade Value Shares
Change 		Shares
Change %
Marshall Wace
26
Marshall Wace
United Kingdom
– -$39K -6,386 Closed
1
2